Outcome measure | Baseline | Post-BCMA | % Change from baseline | p Value | |
---|---|---|---|---|---|
Poon et al10 | Percentage clinically significant potential ADEs | 1.8 | 0.9 | 48.5 | <0.001 |
Percentage serious potential ADEs | 1.3 | 0.6 | 54.1 | <0.001 | |
Percentage life-threatening potential ADEs | 0.03 | 0.01 | 53.9 | 0.34 | |
Franklin et al11 | Mean score of potential error severity* | 2.7 | 2.5 | 0.39 | |
Morris et al14 | n/1000 doses of preventable ADEs† | 0.86/1000 doses | 0.43/1000 doses | 47 | 0.044 |
*Scoring on a scale from 0 to 10 where 0 is no effect and 10 is death.
†Severity was assigned using the National Coordinating Council for Medication Error Reporting and Prevention index. All preventable ADEs were assigned class E (temporary harm that required intervention) except five cases assigned to class G because it was not possible to exclude permanent harm.
ADE, adverse drug event; BCMA, bar code-assisted medication administration.